National Health Investors, Inc.
NHI · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.27 | 4.15 | -1.13 | 0.40 |
| FCF Yield | 1.66% | 1.83% | 1.38% | 1.82% |
| EV / EBITDA | 0.00 | 61.00 | 67.91 | 56.31 |
| Quality | ||||
| ROIC | 0.00% | 1.74% | 1.77% | 1.70% |
| Gross Margin | 0.00% | 62.85% | 96.77% | 96.68% |
| Cash Conversion Ratio | 1.91 | 1.66 | 1.37 | 1.35 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.56% | 4.31% | 5.84% | 6.41% |
| Free Cash Flow Growth | 4.54% | 28.70% | -18.54% | 22.43% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 15.34 | 17.00 | 14.87 |
| Interest Coverage | 0.00 | 3.63 | 0.00 | 3.06 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 78.04 | 0.15 | -544.95 | -806.10 |